Abstract Details

Title A Concentration Response Relationship between the Active Metabolite of Clopidogrel and its Antiplatelet Activity

Topic Cerebrovascular Disease and Interventional Neurology

Presentation(s) (-)

Poster/Presentation
Number 106

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Francis M. Gengo, PharmD (Dent Neurologic Institute) PRESENTER	No disclosure on file
	No disclosure on file
Erica S. Westphal (Dent Neurologic Institute)	The institution of Ms. Westphal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for McKesson Coorporation. The institution of Ms. Westphal has received research support from Dent Neurologic Institute.
Michelle Rainka, PharmD (Dent Neurologic Institute)	Dr. Rainka has stock in Abbvie. Dr. Rainka has stock in acadia. Dr. Rainka has stock in alon. Dr. Rainka has stock in biogen. Dr. Rainka has stock in bristol myers squib. Dr. Rainka has stock in eisai. Dr. Rainka has stock in Lilly. Dr. Rainka has stock in novartis. Dr. Rainka has stock in pfizer. Dr. Rainka has stock in roche. Dr. Rainka has stock in Sage. Dr. Rainka has stock in alkermes.
Vernice E. Bates, MD (Dent Neurologic Institute)	No disclosure on file
Richard J. Barohn, MD, F�鶹��ýӳ�� (University of Missouri)	Dr. Barohn has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for NuFactor. The institution of Dr. Barohn has received research support from FDA OPD R01. Dr. Barohn has received intellectual property interests from a discovery or technology relating to health care.